Abbott: all 1,345 studies
Page 14 of 14. Open to participants first (52), then studies with results posted, then the rest; newest registration first within each.
- An Outpatient Study of the Effectiveness and Safety of Depakote ER in the Treatment of Mania/Bipolar Disorder in Children and AdolescentsCompletedNCT00067262Phase 3
- A Study of ABT-751 in Patients With Recurrent Breast Cancer After Taxane (Taxol or Taxotere) Therapy.CompletedNCT00063102Phase 2
- Evaluate the Survival Benefits of Zemplar Versus Calcijex in Subjects w/ Stage V Chronic Kidney Disease on HemodialysisTerminatedNCT00062699Phase 4
- Effect of Niacin ER/Lovastatin on Peak Walking Time & Claudication Onset Time in Patients With Intermittent ClaudicationCompletedNCT00062556Phase 3
- Study Evaluating the Safety and Effectiveness of ABT-510 in Subjects With Refractory LymphomaCompletedNCT00061672Phase 2
- Study Evaluating the Safety and Efficacy of ABT-510 in Subjects With Locally Advanced or Metastatic Soft Tissue SarcomaCompletedNCT00061659Phase 2
- Safety and Effectiveness of ABT-510 Plus Combination Chemotherapy in Subjects With Non-Small Cell Lung Cancer (NSCLC)TerminatedNCT00061646Phase 2
- An Inpatient Study of the Effectiveness and Safety of Depakote ER in the Treatment of Mania/Bipolar DisorderCompletedNCT00060905Phase 3
- Study of a 6-Month Sustained-Release Formulation of Leuprolide Acetate in Prostate CancerCompletedNCT00056654Not applicable
- A Study of the Human Anti-TNF Antibody Adalimumab for the Induction of Clinical Remission in Subjects With Crohn's DiseaseCompletedNCT00055523Phase 2
- Safety and Effectiveness of Zemplar Injection in Decreasing iPTH Levels in Pediatric ESRD Subjects on HemodialysisCompletedNCT00053547Phase 4
- A Study to Examine the Use of Zemplar to Increase Serum Calcium Levels in ICU SubjectsCompletedNCT00053378Phase 2
- Study of Human Anti-TNF Monoclonal Antibody D2E7 in Subjects With Active Rheumatoid ArthritisCompletedNCT00049751Phase 3
- Safety and Efficacy of Zemplar Capsule in Reducing Serum iPTH Levels in Chronic Kidney Disease Subjects (Daily Dosing)CompletedNCT00048516Phase 3
- Safety and Efficacy of Zemplar Capsule in Reducing Serum iPTH Levels in Chronic Kidney Disease Subjects (Three Times Weekly)CompletedNCT00048451Phase 3
- Safety and Efficacy of Zemplar Capsule in Reducing Serum IPTH Levels in Chronic Kidney Disease Subjects (Three Times Weekly)CompletedNCT00048438Phase 3
- Evaluation of Intravenous Levosimendan Efficacy in the Short Term Treatment of Decompensated Chronic Heart Failure.CompletedNCT00048425Phase 3
- Atrasentan in Treating Patients With Prostate CancerCompletedNCT00046943Phase 3
- Study of Lopinavir, Ritonavir, Tenofovir and Emtricitabine in HIV-Infected Antiretroviral Naïve SubjectsCompletedNCT00043966Phase 3
- Lopinavir/Ritonavir in Combination With Saquinavir Mesylate or Lamivudine/Zidovudine to Explore Metabolic Toxicities in Antiretroviral HIV-Infected SubjectsCompletedNCT00043953Phase 2
- Safety and Efficacy of Atrasentan in Men With Hormone Naive Prostate Cancer Exhibiting Early Signs of Biochemical FailureCompletedNCT00038662Phase 2
- A Study of Two Different Doses of ABT-378/Ritonavir in HIV-Infected Patients Who Have Taken Protease Inhibitors and Non-Nucleoside Reverse Transcriptase InhibitorsCompletedNCT00038636Phase 3
- Amprenavir/Ritonavir, Saquinavir/Ritonavir or Efavirenz in HIV-Infected Subjects Following Failure With Kaletra (ABT-378/Ritonavir) as Their First Protease Inhibitor Based HAARTCompletedNCT00038532Phase 2
- Amprenavir/Ritonavir or Saquinavir/Ritonavir in HIV-Infected Subjects Following Failure With Kaletra as Their Second Protease InhibitorCompletedNCT00038519Phase 2/3
- Effectiveness of ABT-378/Ritonavir Plus Lamivudine Plus Efavirenz Plus Tenofovir DF in HIV-Infected PatientsCompletedNCT00038220Phase 2
- Study of Atrasentan in Men With Non-Metastatic, Hormone-Refractory Prostate CancerCompletedNCT00036556Phase 3
- A Study of Atrasentan in Men With Metastatic, Hormone-Refractory Prostate CancerCompletedNCT00036543Phase 3
- Research Study in Patients With Severe Ulcerative ColitisCompletedNCT00032305Phase 2/3
- Research Study of Visilizumab for Treatment of Acute Graft Versus Host DiseaseCompletedNCT00032292Phase 1/2
- Study of Daclizumab in Patients With Chronic, Persistent AsthmaCompletedNCT00028288Phase 2
- Pilot Study in Patients With Symptomatic Steroid-Naive AsthmaCompletedNCT00024544Phase 2
- Combination Chemotherapy With or Without Monoclonal Antibody Therapy in Treating Patients With Refractory or Relapsed Acute Myelogenous LeukemiaStatus unknownNCT00006045Phase 3
- A Phase III Study Comparing Two Different Anti-HIV Drug Combinations in HIV-Positive Patients Without Previous Anti-HIV Drug TherapyCompletedNCT00004583Phase 3
- A Study to Compare Two Anti-HIV Drug Combinations in HIV-Infected Patients Who Have Previously Received Anti-HIV TreatmentCompletedNCT00004581Phase 3
- A Study of ABT-378/Ritonavir Combination in HIV-Infected Patients Who Have Taken Protease InhibitorsCompletedNCT00004580Phase 1
- ABT-378/Ritonavir in Combination With Reverse Transcriptase Inhibitors in Antiretroviral Naïve HIV-Infected SubjectsCompletedNCT00004578Phase 1/2
- The Safety and Effectiveness of Ritonavir in the Treatment of HIV-Related Kaposi's SarcomaCompletedNCT00002366Phase 2
- The Safety and Effectiveness of Clarithromycin in the Prevention of Mycobacterium Avium Complex (MAC) Infection in HIV-Infected PatientsCompletedNCT00002336Not applicable
- The Safety and Effectiveness of Clarithromycin Plus Ethambutol Used With or Without Clofazimine in the Treatment of MAC in Patients With AIDSCompletedNCT00002331Not applicable
- A Comparison of Two Types of Injected Nutritional Supplements in Patients With AIDS and Pneumocystis Carinii Pneumonia (PCP)CompletedNCT00002275Not applicable
- A Study of Ritonavir/Indinavir Combination in HIV-Infected PatientsCompletedNCT00002223Not applicable
- A Study of Ritonavir (ABT-538) When Used With Nelfinavir in HIV-Infected PatientsCompletedNCT00002201Not applicable
- Phase I Safety Study of Anti-HIV Immune Serum Globulin (Human)CompletedNCT00002036Phase 1
- Long-Term Nutritional Support in Patients With the Acquired Immunodeficiency Syndrome: Comparison of Liposyn III 2 Percent With Liposyn II 20 PercentCompletedNCT00002029Not applicable
- The Safety and Effectiveness of Clarithromycin Plus Zidovudine or Dideoxyinosine in the Treatment of Mycobacterium Avium Complex (MAC) Infections in Children With AIDSCompletedNCT00000971Phase 1